Clinical trial / 2014
A 2-week daily Ascophyllum nodosum seaweed supplement improved iodine status and increased thyroid-stimulating hormone in iodine-insufficient women.
Researchers evaluated the bioavailability of iodine from encapsulated Ascophyllum nodosum seaweed compared to potassium iodide (KI) and examined the effect of 2 weeks of daily supplementation (0.5 g seaweed daily) in iodine-insufficient women. Seaweed iodine was modestly bioavailable at 33% (IQR 28-46%) compared with 59% (IQR 46-74%) from KI (n=22). After 2 weeks of seaweed supplementation (n=42), urinary iodine excretion increased from 78 (IQR 39-114) to 140 (IQR 103-195) μg/l (P<0.001). Thyroid-stimulating hormone increased from 1.5 (IQR 1.2-2.2) to 2.1 (IQR 1.3-2.9) mIU/l (P<0.001), with two participants exceeding the normal range, while other thyroid hormones showed no change.
- Study type
- Intervention trial (bioavailability and 2-week supplementation)
- Who was studied
- Healthy non-pregnant women of childbearing age reporting low dairy and seafood intake (n=22 for bioavailability, n=42 for supplementation)
- What was measured
- Iodine bioavailability, urinary iodine excretion, and thyroid hormone concentrations
THE PAPER
Low-level seaweed supplementation improves iodine status in iodine-insufficient women.
Combet E, Ma ZF, Cousins F, Thompson B, Lean ME. Br J Nutr, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.